Jefferies Starts DaVita (DVA) at Buy; Downgrades Fresenius Medical Care (FMS) to Underperform
Tweet Send to a Friend
Jefferies initiates coverage on DaVita (NYSE: DVA) with a Buy rating and a price target of $86, while downgrading downgrade ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
